Thirty Day Resource Utilization after Chimeric Antigen Receptor (CAR) T Cell Infusion for Hematologic Malignancies

被引：0

作者：

Shah, Gunjan L. ^{[1
]}

Park, Jae ^{[2
]}

Sauter, Craig S. ^{[1
]}

Duck, Elaine ^{[3
]}

Halton, Elizabeth ^{[4
]}

Batlevi, Connie W. ^{[5
]}

Palomba, M. Lia ^{[5
]}

Younes, Anas ^{[5
]}

Geyer, Mark B. ^{[2
]}

Smith, Eric ^{[6
]}

Mailankody, Sham ^{[6
]}

Mead, Elena ^{[7
]}

Santomasso, Bianca ^{[8
]}

Perales, Miguel-Angel ^{[9
]}

Sabbatini, Paul ^{[10
]}

Giralt, Sergio A. ^{[9
]}

Brentjens, Renier ^{[2
]}

Bach, Peter B. ^{[11
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Managed Care Outcomes Anal, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[7] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, 1275 York Ave, New York, NY 10021 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Neurol, Brain Tumor Serv, 1275 York Ave, New York, NY 10021 USA

[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[10] Mem Sloan Kettering Canc Ctr, Gynecol Med Oncol Serv, 1275 York Ave, New York, NY 10021 USA

[11] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[41] Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies
Nagle, Sarah J.
Murphree, Catherine
Raess, Philipp W.
Schachter, Levanto
Chen, Andy
Hayes-Lattin, Brandon
Nemecek, Eneida
Maziarz, Richard T.
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : 455 - 461
[42] Cytopenias after Chimeric Antigen Receptor T-Cells (CAR-T) Infusion; Patterns and Outcomes
Schaefer, Andrew
Saygin, Caner
Maakaron, Joseph
Hoelscher, Tara
Purdin, Zebulun
Robinson, Jacquela
Lamprecht, Misty
Penza, Sam
Brammer, Jonathan E.
Efebera, Yvonne A.
Benson, Don M.
Vasu, Sumithira
Mims, Alice
Blaser, Bradley
Choe, Hannah
Larkin, Karilyn
Long, Meixiao
Rosko, Ashley
Grieselhuber, Nicole
Wall, Sarah
Jaglowski, Samantha
William, Basem M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[43] GEOGRAPHIC TRENDS IN CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY ACCESS AND UTILIZATION
McBride, K.
Snyder, S.
Serrano-Rubio, D.
Gitlin, M.
VALUE IN HEALTH, 2024, 27 (06) : S218 - S218
[44] Chimeric antigen receptor T cells march into T cell malignancies
Jie Tang
Xudong Zhao
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13459 - 13475
[45] Chimeric antigen receptor T cells march into T cell malignancies
Tang, Jie
Zhao, Xudong
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13459 - 13475
[46] Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety-A Systematic Review with Meta-Analysis
Yu, Wen-Liang
Hua, Zi-Chun
CANCERS, 2019, 11 (01):
[47] Chimeric antigen T cell receptor treatment in hematological malignancies
Ali, Natasha
BLOOD RESEARCH, 2019, 54 (02) : 81 - 83
[48] Chimeric antigen receptor T cell immunotherapy for gynecological malignancies
Gao, Yajuan
He, Jing
Wang, Jing
Xu, Haiou
Ma, Lin
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
[49] Chimeric Antigen Receptor (CAR) T-Cell Therapy
Pagel, John M.
West, Howard
JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
[50] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS
Kumar, P.
Wurster, S.
daSilva, T.
Hauser, P.
Neelapu, S. S.
Kontoyiannis, D.
CYTOTHERAPY, 2024, 26 (06) : S10 - S11

← 1 2 3 4 5 →